Biotech China 2014

Leukemia: Duke University

Total Score People Score Events Score
42 31 7
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Thrombosis and Cancer: Emerging Data for the Practicing Oncologist Gary H. Lyman
Treatment of Patients with Locally Advanced Rectal Cancer and Liver Metastases (C03) Brian G. Czito
Special Session David Harpole
Education Sessions H Kim Lyerly
Educations Sessions David Rizzieri
April 6, 2013 AACR Annual Meetings The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Jeremy N. Rich
April 29, 2011 Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies SESSION 2 | Welcome and Introductions Patrick Buckley
Simultaneous Session 2 | Practical Hematopathology | Cells, Chromosomes, and Molecules in AML—Providing Insights Into Classification, Diagnosis, and Prognosis Patrick Buckley
Session 1 | Management of Diabetes in the Oncology Patient Angela Johns
SESSION 2 | Recurrent Molecular Mutations in Acute Myeloid Leukemia Michael B. Datto
SESSION 2 | Determining Immunophenotype in Acute Myeloid Leukemia | At Diagnosis and Beyond Anand Shreeram Lagoo
SESSION 2 | Current Classification of Acute Myeloid Leukemia | Implications of Dysplastic Changes and Cytogenetic and Molecular Abnormalities Patrick Buckley
Debate | Therapy for secondary leukemia in the “robust” elderly patient Arati Rao
Personalizing Health Care Through Genomic Profiling Sandeep S. Dave
Debate | Induction therapy for patients with acute lymphoblastic leukemia should contain asparaginase. Mitchell Horwitz
Debate | Options for chronic myeloid leukemia induction therapy | the choice for a new generation? Joseph Moore
Welcome and Presession Survey Joseph Moore
Leukemia Session Joseph Moore
New Options in Hodgkin Lymphoma Anne W. Beaven
The Future of Chronic Lymphocytic Leukemia Therapy Mark C. Lanasa
Debate | Bendamustine | rituximab is the standard of care for induction therapy of follicular lymphoma. Anne W. Beaven
Welcome and Presession Survey Anne W. Beaven
Lymphoma Session Anne W. Beaven
April 9, 2010 Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies The Biologic Significance of Clonal T-Cells | Session 2 Michael B. Datto
CD30-Positive and Other Cutaneous T-Cell Proliferations | Session 2 Patrick Buckley
General Principles in Treating T-Cell Lymphomas | Session 2 Anne W. Beaven
Classification of T-Cell Lymphomas | Session 2 Anand Shreeram Lagoo
Welcome, Introductions and Presession Survey | Session 2 Patrick Buckley
Simultaneous Session 2 Practical Hematopathology: T-Cell Lymphomas Patrick Buckley
Palliative and End-of-Life Care Gwynn D. Long
Pharmacy Session Tippu Khan
Transplantation Therese Hennig
Treatment Options Patricia H. Davis
Pathophysiology and Diagnosis Mark C. Lanasa
Welcome and Presession Survey Joseph Moore
Leukemia Session Joseph Moore
Interesting Cases and Postsession Survey | Session 2 Anne W. Beaven, Patrick Buckley, Anand Shreeram Lagoo
Case-Based Presentation Myeloproliferative Neoplasms: What Are We All JAKed Up About? Murat O. Arcasoy
Debate Allogeneic Transplantation Is Standard for All Patients Aged < 55 Years With AML in First Remission Who Do Not Have Good-Risk Cytogenetics Nelson J. Chao, Jon Gockerman
The Future of Personalized Therapy: The Application of Genomics and MicroRNA in Guiding Therapy Sandeep S. Dave
Debate Patients With Philadelphia Chromosome–Positive ALL: Transplant Now or Later? Gwynn D. Long
Debate Transplantation vs. Novel, Less Lethal Approaches to MDS Carlos de Castro, Mitchell Horwitz
Bone Marrow Transplantation Workshop Nelson J. Chao
Debate The Best Therapy for Elderly Patients With AML: 7+3 Is Good Enough for Me! Joseph Moore, Arati Rao
Use of New Stem Cell Mobilization Agents for Patients and Healthy Donors Mitchell Horwitz
Recent Advances in Posttransplantation Immune Modulation Following Nonablative Allogeneic Transplantation David Rizzieri
Recent Advances in Cord Blood Transplantation Nelson J. Chao
Debate Fludarabine-Based Regimens Are the Preferred First-line Approach to Patients With CLL David Rizzieri, Mark C. Lanasa
Debate Induction Therapy in Preparation for Transplantation: Immunomodulator or Proteasome Inhibitor? Cristina Gasparetto
How I Treat High-Risk DLBCL Anne W. Beaven
Keynote Address New Therapies for PNH Wendell F. Rosse
Welcome and Presession Survey David Rizzieri
Lymphoma Session Anne W. Beaven
May 30, 2008 ASCO Annual'08 Meeting cancer prevention/epidemiology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
geriatric oncology-- Internal Medicine for the Oncologist Harvey Jay Cohen
health services research-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
tumor biology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
March 25, 2008 CANCER MOLECULAR MARKERS An Integrated Genomic Approach for the Treatment of Patients with Advanced Stage Ovarian Cancer Holly K Dressman
October 11, 2007 Sixth International Colorectal Cancer Congress Novel Combinations of VEGF/VEGFR and mTOR Inhibitors Herbert Hurwitz
How to Use Angiogenesis Inhibitors Safely: Practical Issues Herbert Hurwitz
Should Anti-VEGF Therapy Continue Beyond Progession? Herbert Hurwitz
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.